These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
566 related items for PubMed ID: 21452922
1. Methotrexate chronotherapy is effective against rheumatoid arthritis. To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, Sonemoto E, Shimasaki N, Koyanagi S, Sasaki H, Ieiri I, Higuchi S, Kawakami A, Ueki Y, Eguchi K. Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922 [Abstract] [Full Text] [Related]
3. Dosing time-dependency of the arthritis-inhibiting effect of tacrolimus in mice. Obayashi K, Tomonari M, Yoshimatsu H, Fukuyama R, Ieiri I, Higuchi S, To H. J Pharmacol Sci; 2011 Apr; 116(3):264-73. PubMed ID: 21691040 [Abstract] [Full Text] [Related]
4. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M. Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169 [Abstract] [Full Text] [Related]
8. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate. Seitz M, Zwicker M, Villiger PM. J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386 [Abstract] [Full Text] [Related]
10. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V. Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477 [Abstract] [Full Text] [Related]
11. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. Edwards CK, Zhou T, Zhang J, Baker TJ, De M, Long RE, Borcherding DR, Bowlin TL, Bluethmann H, Mountz JD. J Immunol; 1996 Aug 15; 157(4):1758-72. PubMed ID: 8759766 [Abstract] [Full Text] [Related]
20. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R. Arthritis Rheum; 1999 Oct 15; 42(10):2160-5. PubMed ID: 10524688 [Abstract] [Full Text] [Related] Page: [Next] [New Search]